Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 50090-5915

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 50090-5915). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-01 (Atorvastatin Figure 01)

FDA Label Image

Figure-02 (Atorvastatin Figure 02)

Figure-02 (Atorvastatin Figure 02)
This is a graph showing the cumulative hazard (%) related to the first primary endpoint over a four-year follow-up period, with time intervals from year 1 to year 5. The hazard function appears to increase steadily over time until year 3 before smoothing out. Additionally, there is a reference to a Hazard Ratio (HR) of 0.63 with a confidence interval (0.48-0.83) and a p-value of 0.001.*
FDA Label Image

Figure-03 (Atorvastatin Figure 03)

Figure-03 (Atorvastatin Figure 03)
The text describes a table or chart that shows the percentage of subjects who experienced an event while taking two different doses of Atorvastatin (10mg and 80mg), over a period of time (measured in years). The table also includes a hazard ratio (HR) of 0.78 for Atorvastatin 80mg, with a confidence interval and P-value. No information is available about what the "event" or "major cardiovascular endpoint" refers to.*
FDA Label Image

Structure (Atorvastatin Structure)

FDA Label Image

Label Image (Lbl500905915)

Label Image (Lbl500905915)
The product is a box of 30 tablets containing 40mg of ATORVASTATIN calcium. It can be found at STOREAT 6870 7 OkGAcES £.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.